Skip to main content

Embryology

Volume 714: debated on Tuesday 10 November 2009

Questions

Asked by

To ask Her Majesty's Government further to the Written Answers by Baroness Thornton on 28 October (WA 150–51), whether it is a legal requirement that re-consent procedures should be in place where insufficient information is available to ascertain whether an individual would have objected to the use of their cells to bring about the creation in vitro of an embryo or human admixed embryo for the purposes of proposed research. [HL6148]

It is not a legal requirement that re-consent procedures should be in place where insufficient information is available to ascertain whether an individual would have objected to the use of their cells to bring about the creation in vitro of an embryo or human admixed embryo for the purposes of proposed research.

The condition in paragraph 21(2)(b), (3)(b) and (4)(b) of Schedule 3 to the Human Fertilisation and Embryology Act 1990 is that the information relating to the cell provider that is available to the researcher does not suggest that the individual would have objected to the use of their human cells to bring about the creation in vitro of an embryo or human admixed embryo for the purposes of the research project.

Asked by

To ask Her Majesty's Government further to the Written Answers by Baroness Thornton on 27 October (WA 124) and 2 November (WA 7) stating that research licence applications and renewals are assessed in light of available scientific evidence, why records of relevant scientific publications are not maintained by the Human Fertilisation and Embryology Authority. [HL6213]

The Human Fertilisation and Embryology Authority (HFEA) has advised that relevant publications may be provided by centres when they apply for a research licence or for a renewal of a research licence and by peer reviewers when they submit their reviews of these applications.

The HFEA has a record of all applications and peer reviews submitted, which will be referred to when the HFEA decides whether to grant or renew a research licence. The HFEA may also refer to advice provided by its Scientific and Clinical Advances Advisory Committee when making these decisions.

For this reason, the HFEA does not maintain a record of the type indicated in the Question.